Sera Prognostics, Inc. (BOATS:SERA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jay M. Moyes Other companies: BioCardia, Inc. (Board Member · Since at least Oct 24, 2016); SiNtx Technologies, Inc. (Audit Committee Chair · Since at least Feb 12, 2014); Puma Biotechnology Inc (Director · Since at least Apr 27, 2012); Achieve Life Sciences, Inc. (Director · Aug 1, 2017 – May 31, 2022 · Past); Osiris Therapeutics Inc (Director · Aug 3, 2006 – Feb 12, 2013 · Past); Myriad Genetics, Inc. (Chief Financial Officer · Feb 10, 2006 – Oct 15, 2007 · Past) | Chief Financial Officer · Jul 14, 2021 – Jun 7, 2023 · Past |
| Jeffrey Elliott Other companies: ICON plc (Director · Since at least Jun 1, 2026); Quanterix Corporation (COO of Exact Sciences · Since at least Aug 19, 2024); Exagen Inc. (Director · Sep 18, 2019 – Jun 18, 2020 · Past); EXACT Sciences Corporation (Chief Financial Officer · Nov 8, 2016 – Apr 30, 2024 · Past) | Director · Since at least Mar 20, 2025 |
| Kim Kamdar Other companies: Evofem Biosciences, Inc. (Member of the Board of Directors · Since at least Nov 19, 2014); Singular Genomics Systems Inc (Director · May 26, 2021 – Feb 21, 2025 · Past); Vyome Holdings, Inc. (Director · Oct 5, 2016 – Sep 16, 2020 · Past); Syndax Pharmaceuticals, Inc. (Director · Mar 2, 2016 – Oct 31, 2016 · Past) | Director · Since at least Jul 14, 2021 |
| Sandra A.J. Lawrence Other companies: Brixmor Property Group Inc. (Director · Since at least Dec 24, 2021); Evergy, Inc. (Director · Since at least Jun 4, 2018); American Shared Hospital Services (Director · Sep 7, 2017 – Jun 25, 2021 · Past); Westar Energy Inc (Director · Jan 3, 2006 – Jun 4, 2018 · Past) | Director · Since at least Nov 29, 2021 |
| Douglas Carl Fisher Other companies: CERo Therapeutics Holdings, Inc. (President · Oct 5, 2021 – Feb 14, 2024 · Past); Precipio, Inc. (Director · Sep 26, 2017 – Oct 27, 2023 · Past); Vyome Holdings, Inc. (Director · Oct 5, 2016 – Sep 16, 2020 · Past) | Chief Business Officer · Jul 14, 2021 – Jan 10, 2022 · Past |
| Jane F Barlow Other companies: Viracta Therapeutics Inc (Director · Aug 14, 2021 – Jun 20, 2024 · Past); Momenta Pharmaceuticals Inc (Director · Dec 11, 2019 – Oct 1, 2020 · Past); TherapeuticsMD, Inc. (Director · Mar 27, 2018 – Aug 12, 2019 · Past) | Director · Since at least Apr 11, 2022 |
| Mark Capone Other companies: Mesa Laboratories, Inc. (Director · Since at least Jan 8, 2024); Constellation Alpha Capital Corp (Director · Jul 18, 2022 – Jun 1, 2023 · Past); Myriad Genetics, Inc. (President & C.E.O. · Aug 19, 2016 – Sep 30, 2019 · Past) | Director · Since at least Jun 30, 2026 |
| Mansoor Raza Mirza Other companies: Acrivon Therapeutics, Inc. (Chief Medical Officer · Since at least Apr 9, 2025); Karyopharm Therapeutics Inc. (Director · Since at least Nov 5, 2013) | Director · Since at least Jul 14, 2021 |
| Benjamin G. Jackson Other companies: Myriad Genetics, Inc. (Former E.V.P., General Counsel · Jul 1, 2019 – Apr 12, 2021 · Past) | General Counsel · Since at least Jul 14, 2021 |
| Gregory C Critchfield Other companies: Myriad Genetics, Inc. (President Myriad Genetic Labs · Feb 16, 2006 – Sep 15, 2009 · Past) | Director · Since at least Jul 14, 2021 |
| Robert Gardner Harrison Other companies: Myriad Genetics, Inc. (Chief Information Officer · Jan 1, 2008 – Sep 17, 2014 · Past) | Chief Information Officer · Since at least Nov 1, 2021 |
| Scott Gleason Other companies: OraSure Technologies, Inc. (Interim CFO/SVP IR · Sep 17, 2021 – May 21, 2022 · Past) | Chief Financial Officer · Since at least Aug 19, 2026 |
| Adrienne Lugo | Head of Sales & Strategic Accounts · Since at least Nov 5, 2026 |
| Angie Fox | VP of Clinical Operations · Since at least Nov 5, 2026 |
| Austin Aerts | Chief Financial Officer · Since at least Jun 7, 2023 |
| Cassondra Mize | Head of Marketing · Since at least Nov 5, 2026 |
| Dyaarl Lee Anderson Jr | Chief Commercial Officer · Since at least May 19, 2025 |
| Jay Boniface | Chief Scientific Officer · Since at least Nov 5, 2026 |
| Jeff Elliott | Director · Mar 19, 2025 – Nov 4, 2026 · Past |
| Jennifer Zibuda | Head of Investor Relations · Since at least Aug 19, 2026 |
| John J Boniface | Chief Scientific Officer · Since at least Jul 14, 2021 |
| John M Peltier | SVP of Lab Operations · Jul 14, 2021 – Jul 14, 2021 · Past |
| Joshua Phillips | Director · Since at least Jul 14, 2021 |
| Lee Anderson | Chief Commercial Officer · Since at least May 8, 2025 |
| Liana Burns | Head of Payer, Government & Strategic Partnerships · Since at least Nov 5, 2026 |
| Marcus Dean Wilson | Director · Since at least Jul 14, 2021 |
| Michael R Foley | Chief Medical Officer · Dec 30, 2021 – Jul 12, 2023 · Past |
| Nadia Altomare | Chief Commercial Officer · Jul 14, 2021 – Jun 9, 2023 · Past |
| Nichole L Martin | VP OF Q/R & HIPPA PRIV. OFF · Jul 14, 2021 – Jul 14, 2021 · Past |
| Nikki Martin | VP of Quality and Regulatory · Since at least Nov 5, 2026 |
| Paul Kearney | Chief Data Officer · Since at least Oct 1, 2021 |
| Ryan Trimble | Director · Since at least Jul 14, 2021 |
| Thomas Garite | VP, Clinical Sciences · Jul 14, 2021 – Aug 26, 2021 · Past |
| Tiffany Inglis | Chief Medical Officer & VP Medical Affairs · Since at least Oct 1, 2025 |
| Zhenya Lindgardt | President and CEO · Since at least Nov 8, 2021 |